NCT07024316
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 1, 2025
Completion: Sep 1, 2027